← Open Payments lookup

HEMCHAND KOLLI: Open Payments

NPI 1669552485 · HEMET, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,549 in 133 payments from 32 companies in 2025. Trend: 2023 $2,534 · 2024 $2,309 · 2025 $2,549

Food & beverage: $2,549
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP11$311
Otsuka America Pharmaceutical, Inc.11$284
Novo Nordisk Inc16$230
GlaxoSmithKline, LLC.10$200
Amgen Inc.23$158
Janssen Biotech, Inc.1$150
Lilly USA, LLC11$146
Merck Sharp & Dohme LLC5$119
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$79
Neurocrine BioSciences, Inc.4$79

Products named: REXULTI, TRELEGY ELLIPTA, TREMFYA, FARXIGA, AIRSUPRA, VERQUVO, OTEZLA, Wegovy.

Industry payments across CA — which companies pay providers there.